BRD2 inhibitor

BRD2 inhibitor has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Nov 22, 2022: “cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis”.